Loading...
Portfolio Diversification
Range
Most Diversified
25 instruments
January 9, 2026
Least Diversified
0 instruments
October 20, 2025
Average
18.5 instruments
Most Consistent Holdings
Top 5
BDX99.61%
DXCM99.61%
MRK99.55%
PODD99.55%
NVO99.55%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Eli Lilly (LLY) | 11.25% | 4.83% | 99.09% | - |
| Merck (MRK) | 8.75% | 5.28% | 99.55% | - |
| Novo-Nordisk (NVO) | 8.44% | 2.84% | 99.55% | - |
 Abbott (ABT) | 6% | 3.07% | 99.42% | - |
 AstraZeneca (AZN.L) | 5.98% | 0% | 92.92% | 1/7/2026 |
| DexCom (DXCM) | 5.41% | 5.5% | 99.61% | - |
 Medtronic (MDT.US) | 4.83% | 3.83% | 99.42% | - |
| Insulet (PODD) | 4.33% | 3.11% | 99.55% | - |
 Johnson & Johnson (JNJ) | 3.93% | 4.89% | 72.64% | - |
 Roche (ROG.ZU) | 3.62% | 0% | 92.92% | 1/7/2026 |
 Sanofi (SAN.PA) | 3.61% | 0% | 92.79% | 1/7/2026 |
| BD (BDX) | 3.58% | 2.59% | 99.61% | - |
 Bristol-Myers Squibb (BMY) | 2.92% | 4.32% | 65.43% | - |
 Tandem Diabetes (TNDM) | 2.82% | 3.1% | 99.48% | - |
 Ascendis Pharma (ASND) | 2.69% | 4.93% | 53.67% | - |
 Neurocrine Biosciences (NBIX) | 2.69% | 4.54% | 53.48% | - |
 Halozyme (HALO) | 2.42% | 3.45% | 51.79% | - |
 Alkermes (ALKS) | 2.4% | 4.62% | 53.28% | - |
 Bayer (BAYN.DE) | 2.32% | 0% | 45.68% | 1/3/2024 |
 MannKind (MNKD) | 2.26% | 1.92% | 68.1% | - |
 Rhythm Pharmaceuticals (RYTM) | 1.49% | 3.72% | 30.6% | - |
 Pfizer (PFE) | 1.45% | 5.65% | 29.63% | - |
 Almirall (ALM.MC) | 1.03% | 0% | 45.68% | 1/3/2024 |
 GlaxoSmithKline (GSK) | 0.99% | 0% | 23.91% | 1/8/2025 |
 Sandoz (SDZNY) | 0.59% | 0% | 13.58% | 8/1/2024 |
 GSK (GSK.L) | 0.44% | 0% | 11.5% | 1/3/2024 |
 Viking Therapeutics (VKTX) | 0.31% | 5.21% | 6.63% | - |
 Amgen (AMGN) | 0.3% | 4.56% | 6.69% | - |
 Vertex (VRTX) | 0.29% | 4.23% | 6.63% | - |
 West Pharma (WST) | 0.26% | 4.38% | 6.63% | - |
 Lexicon Pharmaceuticals (LXRX) | 0.25% | 0% | 11.57% | 1/3/2024 |
 AstraZeneca (AZN) | 0.25% | 3.92% | 6.69% | - |
 Hansoh Pharmaceutical Group (3692.HK) | 0.2% | 3.42% | 6.56% | - |
 Beta Bionics Inc (BBNX) | 0.11% | 1.56% | 6.69% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Eli Lilly (LLY) | 4.38% | 10.2% |
| Johnson & Johnson (JNJ) | 5.69% | 6.79% |
| Merck (MRK) | 6.25% | 6.78% |
| Ascendis Pharma (ASND) | 3.82% | 5.98% |
| AstraZeneca (AZN.L) | 4.54% | 5.71% |
| Insulet (PODD) | 4.37% | 5.34% |
| DexCom (DXCM) | 8.7% | 5.3% |
| Neurocrine Biosciences (NBIX) | 5.34% | 5.27% |
| Medtronic (MDT.US) | 5.6% | 5.03% |
| Halozyme (HALO) | 4.23% | 4.78% |
| Roche (ROG.ZU) | 5% | 4.53% |
| Abbott (ABT) | 4.59% | 4.49% |
| Pfizer (PFE) | 5.13% | 4.42% |
| Bristol-Myers Squibb (BMY) | 5.1% | 4.01% |
| Alkermes (ALKS) | 4.26% | 3.77% |
| BD (BDX) | 5.12% | 3.61% |
| MannKind (MNKD) | 4.12% | 3.44% |
| Sanofi (SAN.PA) | 3.96% | 3.01% |
| Tandem Diabetes (TNDM) | 3.54% | 2.66% |
| Novo-Nordisk (NVO) | 3.88% | 2.63% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.